| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |